Original language | English |
---|---|
Pages (from-to) | 831-833 |
Number of pages | 3 |
Journal | Nature Biotechnology |
Volume | 18 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2000 |
Biopharmaceutical benchmarks: Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline
Research output: Contribution to journal › Review article › peer-review